Nautilus Biotechnology, Inc. (NAUT) Tops Q4 EPS by 3c
Tweet
Share
E-mailGet Alerts NAUT Hot Sheet
Join SI Premium – FREE
Nautilus Biotechnology, Inc. (NASDAQ: NAUT) reported Q4 EPS of ($0.11), $0.03 better than the analyst estimate of ($0.14).
For earnings history and earnings-related data on Nautilus Biotechnology, Inc. (NAUT) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
- Cerebras Systems (CBRS) Misses Q1 EPS, Revenues Beat
- H.C. Wainwright Reiterates Buy Rating on Entera Bio (ENTX)
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
